On the public citation graph
The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man
0 signed · 65 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/bf01747716openalex-snapshot
Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe
inferredcites →https://doi.org/10.1007/bf01747863openalex-snapshot
Über die radioimmunologische Bestimmung von Insulin im Blut
inferredcites →https://doi.org/10.1007/bf01851236openalex-snapshot
The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man
inferredcites →https://doi.org/10.1016/s0140-6736(57)92595-3openalex-snapshot
USE OF GLUCOSE OXIDASE, PEROXIDASE, AND O-DIANISIDINE IN DETERMINATION OF BLOOD AND URINARY GLUCOSE
inferredcites →https://doi.org/10.1016/s0140-6736(59)90339-3openalex-snapshot
STAPHYLOCOCCI IN HOSPITALS
inferredcites →https://doi.org/10.1016/s0140-6736(78)92466-2openalex-snapshot
SUCROSE MALABSORPTION IN MAN AFTER INGESTION OF α-GLUCOSIDEHYDROLASE INHIBITOR
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/chem.202600033openalex-snapshot
Discovery of a Novel Microbial Glycoside Hydrolase Directing Formation of New α‐Amylase Inhibitors
inferred← citeshttps://doi.org/10.1002/star.201200194openalex-snapshot
Amylase inhibitors and their biomedical applications
inferred← citeshttps://doi.org/10.1007/978-3-642-73461-8_2openalex-snapshot
Microbial α-Glucosidase Inhibitors: Chemistry, Biochemistry, and Therapeutic Potential
inferred← citeshttps://doi.org/10.1007/978-3-642-73583-7_6openalex-snapshot
The Pharmacological Rationale of Diabetes Mellitus Therapy with Acarbose
inferred← citeshttps://doi.org/10.1007/978-3-642-73583-7_8openalex-snapshot
Pharmacodynamics of Acarbose: Clinical Investigations
inferred← citeshttps://doi.org/10.1007/978-3-642-85454-5_246openalex-snapshot
Untersuchungen zur Wirkung des Glucosidase-Inhibitors Bay g 5421 beim Diabetes vom Erwachsenentyp
inferred← citeshttps://doi.org/10.1007/978-3-662-09127-2_21openalex-snapshot
Clinical Pharmacology of Glucosidase Inhibitors
inferred← citeshttps://doi.org/10.1007/bf00257345openalex-snapshot
Effect of acarbose on exocrine and endocrine pancreatic function in the rat
inferred← citeshttps://doi.org/10.1007/bf00257784openalex-snapshot
Improvement of metabolic control in insulin dependent diabetics treated with the ?-glucosidase inhibitor Acarbose for two months
inferred← citeshttps://doi.org/10.1007/bf00542422openalex-snapshot
Effect of acarbose on carbohydrate tolerance during administration of a fibre-free formula diet on healthy subjects
inferred← citeshttps://doi.org/10.1007/bf01297101openalex-snapshot
Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man
inferred← citeshttps://doi.org/10.1007/bf01851236openalex-snapshot
The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man
inferred← citeshttps://doi.org/10.1016/0006-2952(84)90419-2openalex-snapshot
Metabolic effects of acarbose administration in normal and diabetic rats
inferred← citeshttps://doi.org/10.1016/0009-8981(81)90035-8openalex-snapshot
Effect of α-glucosidase inhibitor on human pancreatic and salivary α-amylase
inferred← citeshttps://doi.org/10.1016/0026-0495(83)90117-8openalex-snapshot
Exocrine and endocrine pancreatic function in rats treated with α-glucosidase inhibitor (acarbose)
inferred← citeshttps://doi.org/10.1016/0026-0495(88)90195-3openalex-snapshot
Intestinal and metabolic responses to an α-glucosidase inhibitor in normal volunteers
inferred← citeshttps://doi.org/10.1016/0091-3057(83)90314-3openalex-snapshot
Effects of acarbose on food intake, body weight and fat depots in lean and obese rats
inferred← citeshttps://doi.org/10.1016/0091-3057(86)90030-4openalex-snapshot
Effects of acarbose in rats are influenced by the type of dietary starch
inferred← citeshttps://doi.org/10.1016/0168-8227(90)90106-4openalex-snapshot
Effect of Gymnema sylvestre, R.Br. on glucose homeostasis in rats
inferred← citeshttps://doi.org/10.1016/j.bpg.2004.09.001openalex-snapshot
Modern, new pharmacotherapy for obesity. A gastrointestinal approach
inferred← citeshttps://doi.org/10.1016/j.nutres.2005.06.005openalex-snapshot
Effect of Touchi extract on blood lipids in hypertriglyceridemic subjects and Sprague-Dawley rats
inferred← citeshttps://doi.org/10.1016/j.phrs.2016.09.029openalex-snapshot
Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs—A mechanistic revisit to understand their mode of action
inferred← citeshttps://doi.org/10.1016/j.synbio.2024.03.006openalex-snapshot
Acarbose glycosylation by AcbE for the production of acarstatins with enhanced α-amylase inhibitory activity
inferred← citeshttps://doi.org/10.1016/s0011-393x(00)88015-7openalex-snapshot
Comparison of the effects of acarbose and voglibose on plasma glucose, endogenous insulin sparing, and gastrointestinal adverse events in obese subjects: a randomized, placebo-controlled, double-blind, three-way crossover study
inferred← citeshttps://doi.org/10.1016/s0021-9258(19)69512-8openalex-snapshot
An example of enzyme hysteresis. The slow and tight interaction of some fully competitive inhibitors with small intestinal sucrase.
inferred← citeshttps://doi.org/10.1016/s0149-2918(97)80096-3openalex-snapshot
Comparison of the effects of acarbose and voglibose in healthy subjects
inferred← citeshttps://doi.org/10.1016/s0248-8663(89)80039-6openalex-snapshot
Inhibiteurs des alpha-glucosidases: une nouvelle approche thérapeutique du diabète et des hypoglycémies fonctionnelles
inferred← citeshttps://doi.org/10.1016/s0271-5317(03)00028-9openalex-snapshot
Long-term ingestion of Touchi-extract, an α-glucosidase inhibitor, by borderline and mild type-2 diabetic subjects is safe and significantly reduces blood glucose levels
inferred← citeshttps://doi.org/10.1016/s0955-2863(01)00149-8openalex-snapshot
Efficacy and safety of Touchi extract, an α-glucosidase inhibitor derived from fermented soybeans, in non-insulin-dependent diabetic mellitus
inferred← citeshttps://doi.org/10.1016/s1542-3565(04)00667-6openalex-snapshot
A randomized controlled trial of acarbose in hepatic encephalopathy
inferred← citeshttps://doi.org/10.1038/emm.2016.6openalex-snapshot
Pancreatic regulation of glucose homeostasis
inferred← citeshttps://doi.org/10.1038/s41387-021-00152-5openalex-snapshot
Effects of alpha-glucosidase-inhibiting drugs on acute postprandial glucose and insulin responses: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1046/j.1365-2125.1999.00038.xopenalex-snapshot
Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias
inferred← citeshttps://doi.org/10.1046/j.1463-1326.2000.00065.xopenalex-snapshot
Treatment of familial hypertriglyceridaemia with acarbose
inferred← citeshttps://doi.org/10.1093/ajcn/41.3.511openalex-snapshot
Optimum effectiveness of intestinal α-glucosidase inhibitors: Importance of uniform distribution through a meal
inferred← citeshttps://doi.org/10.1093/jn/119.3.388openalex-snapshot
Effect of Acarbose (BAY-g-5421) on Expression of Noninsulin-Dependent Diabetes Mellitus in Sucrose-Fed SHR/N-Corpulent Rats
inferred← citeshttps://doi.org/10.1093/jn/131.8.2105openalex-snapshot
Long-Term Ingestion of a Fermented Soybean-Derived Touchi-Extract with α-Glucosidase Inhibitory Activity Is Safe and Effective in Humans with Borderline and Mild Type-2 Diabetes
inferred← citeshttps://doi.org/10.1111/j.0954-6820.1986.tb19118.xopenalex-snapshot
α‐GLUCOSIDASE INHIBITION IN OBESITY
inferred← citeshttps://doi.org/10.1111/j.1365-2362.1994.tb02256.xopenalex-snapshot
Efficacy of α‐glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia
inferred← citeshttps://doi.org/10.1111/j.1440-1681.1987.tb01884.xopenalex-snapshot
THE EFFECT OF TWO NEW α‐GLUCOSIDASE INHIBITORS ON METABOLIC RESPONSES TO A MIXED MEAL IN NORMAL VOLUNTEERS
inferred← citeshttps://doi.org/10.1111/j.1464-5491.1987.tb00851.xopenalex-snapshot
Pharmacological Modification of Digestion and Absorption
inferred← citeshttps://doi.org/10.1111/j.1464-5491.1993.tb00030.xopenalex-snapshot
Long‐term Effect of Acarbose on Glycaemic Control in Non‐insulin‐dependent Diabetes Mellitus: A Placebo‐controlled Double‐blind Study
inferred← citeshttps://doi.org/10.1111/j.1464-5491.1993.tb00079.xopenalex-snapshot
The Effect of Acarbose on Blood Glucose Profiles of Type 2 Diabetic Patients Receiving Insulin Therapy
inferred← citeshttps://doi.org/10.1136/openhrt-2015-000327openalex-snapshot
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
inferred← citeshttps://doi.org/10.1155/2020/8138195openalex-snapshot
Alleviating the Hydrolysis of Carbohydrates, Tangzhiqing (TZQ) Decreased the Postprandial Glycemia in Healthy Volunteers: An Eight‐Period Crossover Study
inferred← citeshttps://doi.org/10.1177/1098612x14556559openalex-snapshot
Effect of acarbose on postprandial blood glucose concentrations in healthy cats fed low and high carbohydrate diets
inferred← citeshttps://doi.org/10.1210/edrv.20.6.0383openalex-snapshot
Current and Potential Drugs for Treatment of Obesity
inferred← citeshttps://doi.org/10.1586/14779072.6.2.153openalex-snapshot
Acarbose: oral antidiabetes drug with additional cardiovascular benefits
inferred← citeshttps://doi.org/10.2147/dmsott.s7005openalex-snapshot
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
inferred← citeshttps://doi.org/10.2165/00002018-199411060-00005openalex-snapshot
A Risk-Benefit Appraisal of Acarbose in the Management of Non-Insulin-Dependent Diabetes Mellitus
inferred← citeshttps://doi.org/10.2165/00002512-199609060-00005openalex-snapshot
Oral Antidiabetic Drug Use in the Elderly
inferred← citeshttps://doi.org/10.2174/157339908786241133openalex-snapshot
The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism
inferred← citeshttps://doi.org/10.2460/javma.2000.216.1265openalex-snapshot
Effect of the α-glucosidase inhibitor acarbose on control of glycemia in dogs with naturally acquired diabetes mellitus
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.